1. Home
  2. TENX vs RVP Comparison

TENX vs RVP Comparison

Compare TENX & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TENX
  • RVP
  • Stock Information
  • Founded
  • TENX 1967
  • RVP 1994
  • Country
  • TENX United States
  • RVP United States
  • Employees
  • TENX N/A
  • RVP N/A
  • Industry
  • TENX Biotechnology: Pharmaceutical Preparations
  • RVP Medical/Dental Instruments
  • Sector
  • TENX Health Care
  • RVP Health Care
  • Exchange
  • TENX Nasdaq
  • RVP Nasdaq
  • Market Cap
  • TENX 19.5M
  • RVP 18.6M
  • IPO Year
  • TENX N/A
  • RVP 2001
  • Fundamental
  • Price
  • TENX $5.52
  • RVP $0.60
  • Analyst Decision
  • TENX Strong Buy
  • RVP
  • Analyst Count
  • TENX 4
  • RVP 0
  • Target Price
  • TENX $20.67
  • RVP N/A
  • AVG Volume (30 Days)
  • TENX 67.4K
  • RVP 60.0K
  • Earning Date
  • TENX 11-13-2024
  • RVP 11-14-2024
  • Dividend Yield
  • TENX N/A
  • RVP N/A
  • EPS Growth
  • TENX N/A
  • RVP N/A
  • EPS
  • TENX N/A
  • RVP N/A
  • Revenue
  • TENX N/A
  • RVP $38,265,097.00
  • Revenue This Year
  • TENX N/A
  • RVP N/A
  • Revenue Next Year
  • TENX N/A
  • RVP N/A
  • P/E Ratio
  • TENX N/A
  • RVP N/A
  • Revenue Growth
  • TENX N/A
  • RVP N/A
  • 52 Week Low
  • TENX $2.77
  • RVP $0.56
  • 52 Week High
  • TENX $27.36
  • RVP $1.34
  • Technical
  • Relative Strength Index (RSI)
  • TENX 52.17
  • RVP 37.28
  • Support Level
  • TENX $5.70
  • RVP $0.62
  • Resistance Level
  • TENX $6.01
  • RVP $0.75
  • Average True Range (ATR)
  • TENX 0.48
  • RVP 0.03
  • MACD
  • TENX -0.06
  • RVP 0.00
  • Stochastic Oscillator
  • TENX 17.65
  • RVP 1.33

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: